Table 1.
Clinical profile of asthmatic patients (n = 467)
| Clinical profile | Polyp-positive | Polyp-negative | P-value |
|---|---|---|---|
| Number of subjects (n) | 158 | 309 | |
| Age [year, mean (range)] | 46.24 (17.93-76.86) | 47.00 (15.40 - 77.88) | 0.56 |
| Sex (n, male/female) | 55/103 | 100/209 | 0.60 |
| Total smoker (Current Smoker; Ex-Smoker) (%) | 27.21 (11.39; 15.82) | 27.83 (11.33; 16.50) | 0.93 |
| Body mass index (kg/m2) | 23.95 ± 3.00 | 24.53 ± 3.51 | 0.06 |
| % fall of FEV1 by aspirin provocation | 12.22 ± 14.39 | 6.78 ± 11.46 | < 0.0001 |
| Blood eosinophil (%) | 6.92 ± 6.23 | 5.98 ± 6.00 | 0.12 |
| PC20 methacholine (mg/ml) | 5.83 ± 8.87 | 6.88 ± 8.62 | 0.23 |
| Total IgE (IU/ml) | 298.35 ± 469.67 | 368.39 ± 654.01 | 0.19 |
| FEV1 (% predicted) | 89.67 ± 15.76 | 91.79 ± 17.33 | 0.18 |
| FVC (% predicted) | 89.02 ± 12.65 | 87.68 ± 14.56 | 0.30 |
| Positive rate of skin test (%) | 51.90 | 57.61 | 0.24 |
| Positive rate of aspirin intolerance (%) | 41.77 | 15.53 | < 0.0001 |
Values are mean ± SE. BMI, body mass index.